Triple
T23399884
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | CYP2D6 |
E559472
|
entity |
| Predicate | geneFamily |
P149310
|
FINISHED |
| Object | CYP2D gene cluster |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: CYP2D gene cluster | Statement: [CYP2D6, geneFamily, CYP2D gene cluster]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: CYP2D gene cluster Context triple: [CYP2D6, geneFamily, CYP2D gene cluster]
-
A.
CYP2D6
chosen
CYP2D6 is a highly polymorphic cytochrome P450 enzyme that plays a major role in the metabolism of many drugs, contributing significantly to interindividual variability in drug response.
-
B.
CYP2B6
CYP2B6 is a human liver cytochrome P450 enzyme that plays a key role in the metabolism of various drugs and xenobiotics.
-
C.
CYP1A2
CYP1A2 is a liver enzyme of the cytochrome P450 family that plays a key role in the metabolism of various drugs and xenobiotics.
-
D.
CYP2C19
CYP2C19 is a liver enzyme of the cytochrome P450 family that plays a key role in the metabolism of various drugs, including certain antidepressants, proton pump inhibitors, and antiplatelet agents.
-
E.
CYP3A5
CYP3A5 is a liver-expressed cytochrome P450 enzyme that metabolizes various drugs and xenobiotics, contributing to interindividual variability in drug clearance.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: geneFamily Context triple: [CYP2D6, geneFamily, CYP2D gene cluster]
-
A.
geneFamilyMembers
chosen
Indicates that the related entities belong to the same gene family, representing genes that share common ancestry and functional or sequence similarity.
-
B.
featuresFamilyFrom
Indicates that something includes or presents a family originating from or associated with a specified source.
-
C.
breedingFamily
Indicates that one entity belongs to or is part of the family group used for breeding or reproduction with the other entity.
-
D.
globalFamily
Indicates a familial or kinship relationship that extends across national or geographic boundaries, connecting family members living in different parts of the world.
-
E.
geneType
Indicates the specific category or classification of a gene based on its functional or structural characteristics.
- F. None of above.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e24549610c8190a069d6411ce5f661 |
completed | April 17, 2026, 2:35 p.m. |
| NER | Named-entity recognition | batch_69f1a4dedfcc8190ab93cec3c3d15c53 |
completed | April 29, 2026, 6:27 a.m. |
| PD | Predicate disambiguation | batch_69f061dde2e481908308952f9c0d3c2e |
completed | April 28, 2026, 7:29 a.m. |
Created at: April 17, 2026, 5:37 p.m.